Name: ORUKA THERAPEUTICS INC (ORKA) Stock
Brand: ORUKA THERAPEUTICS INC
Rating: 7 (3 reviews)

ORKA Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Chartmill

Oruka Therapeutics Inc (NASDAQ:ORKA) Reports Q3 2025 Results, Beats EPS Estimates and Provides Clinical Pipeline Updates

7 days ago - By: Benzinga - Mentions: GILD CRWV CPSH VEEV

This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

7 days ago - By: Benzinga - Mentions: CSCO DLTR AZO FDX ...

AutoZone To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday

7 days ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

7 days ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

21 days ago - By: Zacks Investment Research

Wall Street Analysts Predict a 63.59% Upside in Oruka Therapeutics, Inc. (ORKA): Here's What You Should Know

22 days ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics to Present at Multiple November Investor Conferences

22 days ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics to Present at Multiple November Investor Conferences

2 months ago - By: Stocktwits - Mentions: MLTX SLRN

MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades

2 months ago - By: Investor's Business Daily - Mentions: MLTX

MoonLake Crashes 89% On Mixed Results For Skin Disease Treatment

2 months ago - By: Investor's Business Daily - Mentions: AAPL ABBV

Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker

2 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces $180 Million Private Placement

2 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces $180 Million Private Placement

2 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001

2 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001

3 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

4 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September

4 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September

5 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer

5 months ago - By: Oruka Therapeutics, Inc.

Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer

6 months ago - By: Yahoo Finance - Mentions: MLTX LUV

Fertility financing 101: How to afford IVF

6 months ago - By: Yahoo Finance - Mentions: MLTX PTON AAPL

H.C. Wainwright Maintains Buy Rating on MoonLake Immunotherapeutics (MLXT), Keeps PT

6 months ago - By: Yahoo Finance - Mentions: MLTX RXRX AAPL